ConcertAI

ConcertAI offers data products for medical applications. The firm also provides patient insights solutions and collaborates on research as a service.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Series C29 Mar, 2022
***
***
***
Series B13 Jan, 2020
***
***
***
M/A1 Dec, 2017
***
***
***
Corporate1 Dec, 2011
***
***
***

*** - To view the data, please log into your account or create a new one.

News related to ConcertAI66

Filter by
Sort by
ConcertAI
Jun 10, 2024 Show on chart

ConcertAI Appoints Timothy Albury as Chief Financial Officer

Leading Cancer Epidemiologist with Long Academic and Industry Career to Lead Regulatory and Registry Practice in Oncology and Hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ – ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Sol...

ConcertAIhttps://www.concertai.com/news/appoints-timothy-albury-as-chief-financial-officer
ConcertAI
Jun 10, 2024 Show on chart

ConcertAI Appoints Timothy Albury as Chief Financial Officer

PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today...

https://www.prnewswire.com/news-releases/concertai-appoints-timothy-albury-as-chief-financial-officer-302167714.html
ConcertAI
Jun 6, 2024 Show on chart

Nick Jones Appointed SVP and GM Commercial Solutions

Leading Cancer Epidemiologist with Long Academic and Industry Career to Lead Regulatory and Registry Practice in Oncology and Hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ – ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Sol...

ConcertAIhttps://www.concertai.com/news/nick-jones-appointed-svp-and-gm-commercial-solutions
ConcertAI
Jun 4, 2024 Show on chart

2024 ASCO Annual Meeting study demonstrates that AI models for predicting patient availability for clinical trials showed a 2 – 4x improvement over traditional approaches

Ryan Kennedy brings over 20 years’ experience leading technical innovation in the clinical research industry CAMBRIDGE, Mass., Jan. 24, 2024 /PRNewswire/ – ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data f...

ConcertAIhttps://www.concertai.com/news/2024-asco-annual-meeting-study-demonstrates-that-ai-models-for-predicting-patient-availability-for-clinical-trials-showed-a-2-4x-improvement-over-traditional-approaches
ConcertAI
Jun 4, 2024 Show on chart

ConcertAI: 2024 ASCO Annual Meeting study demonstrates that AI ...

PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) solutions for clinical research, announced the....

https://www.prnewswire.com/news-releases/concertai-2024-asco-annual-meeting-study-demonstrates-that-ai-models-for-predicting-patient-availability-for-clinical-trials-showed-a-2--4x-improvement-over-traditional-approaches-302162783.html
Show more (61)

Investors2

Sixth StreetSixth Street
Declaration PartnersDeclaration Partners

ConcertAI Twitter